BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28134694)

  • 1. Pulmonary Opacities and Bronchiectasis Avid on 68Ga-PSMA PET.
    Bouchelouche K; Vendelbo MH
    Clin Nucl Med; 2017 Apr; 42(4):e216-e217. PubMed ID: 28134694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer.
    Aydin F; Akçal A; Ünal B; Sezgin Göksu S; Güngör F
    Clin Nucl Med; 2017 May; 42(5):358-360. PubMed ID: 28240656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls.
    Keidar Z; Gill R; Goshen E; Israel O; Davidson T; Morgulis M; Pirmisashvili N; Ben-Haim S
    Cancer Imaging; 2018 Nov; 18(1):39. PubMed ID: 30382889
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Damjanovic J; Janssen JC; Furth C; Diederichs G; Walter T; Amthauer H; Makowski MR
    Cancer Imaging; 2018 May; 18(1):20. PubMed ID: 29769114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.
    Sahlmann CO; Meller B; Bouter C; Ritter CO; Ströbel P; Lotz J; Trojan L; Meller J; Hijazi S
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):898-905. PubMed ID: 26563122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute Cortical Infarct Showing Uptake on 68Ga-PSMA PET/CT.
    Chan M; Hsiao E
    Clin Nucl Med; 2017 Feb; 42(2):110-111. PubMed ID: 27997426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT.
    Chan M; Schembri GP; Hsiao E
    Clin Nucl Med; 2017 Jan; 42(1):56-57. PubMed ID: 27764044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental Metastatic Melanoma Identified on 68Ga-Prostate-Specific Membrane Antigen PET/CT for Metastatic Prostate Cancer.
    Snow HA; Hofman MS; Mitchell CA; Gyorki DE; Smith MJF
    Clin Nucl Med; 2018 Jul; 43(7):509-511. PubMed ID: 29742609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 68Ga-DOTATOC and 68Ga-PSMA PET/CT Unmasked a Case of Prostate Cancer With Neuroendocrine Differentiation.
    Chen S; Cheung SK; Wong KN; Wong KK; Ho CL
    Clin Nucl Med; 2016 Dec; 41(12):959-960. PubMed ID: 27764046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.
    Shetty D; Loh H; Bui C; Mansberg R; Hadjashrafi A; Do V
    Clin Nucl Med; 2016 Oct; 41(10):776-8. PubMed ID: 27556788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma.
    Bhardwaj H; Stephens M; Bhatt M; Thomas PA
    Clin Nucl Med; 2016 Dec; 41(12):968-969. PubMed ID: 27749413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Imaging in Neuroendocrine Differentiation of Prostate Cancer: 68Ga-PSMA Versus 68Ga-DOTA NOC PET-CT.
    Usmani S; Ahmed N; Marafi F; Rasheed R; Amanguno HG; Al Kandari F
    Clin Nucl Med; 2017 May; 42(5):410-413. PubMed ID: 28240661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental Detection of Head and Neck Squamous Cell Carcinoma on 68Ga-PSMA-11 PET/CT.
    Lawhn-Heath C; Flavell RR; Glastonbury C; Hope TA; Behr SC
    Clin Nucl Med; 2017 Apr; 42(4):e218-e220. PubMed ID: 28166149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspecific Uptake of 68GA-PSMA in Paget Disease of the Bone.
    Bourgeois S; Gykiere P; Goethals L; Everaert H; De Geeter FW
    Clin Nucl Med; 2016 Nov; 41(11):877-878. PubMed ID: 27556795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga-PSMA Uptake in Middle Lobe Syndrome.
    Pedersen MA; Bouchelouche K; Vendelbo MH
    Clin Nucl Med; 2018 Oct; 43(10):e376-e377. PubMed ID: 30036250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental Detection of Thyroid Metastases From Renal Cell Carcinoma Using 68Ga-PSMA PET/CT to Assess Prostate Cancer Recurrence.
    Zacho HD; Nielsen JB; Dettmann K; Haberkorn U; Petersen LJ
    Clin Nucl Med; 2017 Mar; 42(3):221-222. PubMed ID: 28033223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
    Acar E; Kaya GÇ
    Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.
    Demirkol MO; Kiremit MC; Acar O; Ucar B; Saglican Y
    Clin Nucl Med; 2017 May; 42(5):403-405. PubMed ID: 28319496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection Efficacy of Hybrid
    Einspieler I; Rauscher I; Düwel C; Krönke M; Rischpler C; Habl G; Dewes S; Ott A; Wester HJ; Schwaiger M; Maurer T; Eiber M
    J Nucl Med; 2017 Jul; 58(7):1081-1087. PubMed ID: 28209912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.